Watch for Confusion Between Fiasp and NovoLog

Reps will promote the new insulin aspart (Fiasp, FEE-asp) as an "ultrafast-acting" mealtime insulin for adults.

Think of Fiasp as similar to NovoLog. They're both insulin aspart from the same company...except Fiasp has an additive to speed absorption.

You may hear that Fiasp starts working about 5 minutes faster than NovoLog. But this isn't clinically significant most of the time.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals